Janux Therapeutics, Inc. - JANX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 3.3% 1,993,837 View
Aug 14, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 3.3% 1,993,837 View
Aug 14, 2026 SCHEDULE 13G/A Steven A. Cohen 3.3% 1,993,837 View
Aug 13, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP Ltd. 0.3% 172,229 View
Jul 28, 2026 SCHEDULE 13G/A BlackRock, Inc. 6.7% 4,098,457 View
May 15, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 6.9% 4,196,409 View
May 12, 2026 SCHEDULE 13G STATE STREET CORPORATION 4.1% 2,464,017 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 4.2% 2,535,724 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 4.2% 2,535,724 View
Apr 29, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Steven A. Cohen 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Steven A. Cohen 5.0% 3,069,759 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.